Testing effectiveness (Phase 2)Ended earlyNCT04096560What this trial is testingTAK-994 in Adults With Type 1 and Type 2 NarcolepsyWho this might be right forNarcolepsy Type 1 (NT1)Narcolepsy Type 2 (NT2) Takeda 97
Early research (Phase 1)Study completedNCT01093508What this trial is testingSingle-dose Safety Study of APD916 in Healthy VolunteersWho this might be right forNarcolepsy With or Without Cataplexy Arena Pharmaceuticals 72
Large-scale testing (Phase 3)Study completedNCT02611687What this trial is testingEfficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label PeriodWho this might be right forNarcolepsy With CataplexyNarcolepsy Without Cataplexy Bioprojet 110
Not applicableNo Longer AvailableNCT03433131What this trial is testingExpanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without CataplexyWho this might be right forNarcolepsy Without CataplexyNarcolepsy With Cataplexy Harmony Biosciences Management, Inc.
Testing effectiveness (Phase 2)Study completedNCT01183312What this trial is testingFlumazenil for the Treatment of Primary HypersomniaWho this might be right forHypersomniaPrimary HypersomniaIdiopathic Hypersomnia+1 more Lynn Marie Trotti 10
Testing effectiveness (Phase 2)Study completedNCT02512588What this trial is testingSafety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2Who this might be right forIdiopathic HypersomniaNarcolepsy Without Cataplexy Balance Therapeutics 120
Not applicableLooking for participantsNCT01793168What this trial is testingRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordWho this might be right forRare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more Sanford Health 20,000